
Hdglim M 1mg/500mg Tablet SR
Marketer
Medrix Labs Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Hdglim M 1mg/500mg Tablet SR
Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation assists in regulating blood glucose. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with its symptoms—sweating, lightheadedness, headache, tremor—and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac issues should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and supplementary blood tests to assess blood cell counts and liver function may be recommended.
Primary Ingredients of Hdglim M 1mg/500mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Hdglim M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Hdglim M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Hdglim M 1mg/500mg sustained-release tablet should be administered with a meal.
Common Side effects of Hdglim M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Hdglim M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Hdglim M 1mg/500mg Sustained-Release tablet should be administered with a meal.
How Hdglim M 1mg/500mg Tablet SR works:
Each Hdglim M 1mg/500mg sustained-release tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), both used to manage diabetes. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin's action is threefold: it decreases hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Hdglim M 1mg/500mg SR tablets is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Hdglim M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingUNSAFE
Prolonged-release Hdglim M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Hdglim M 1mg/500mg Tablet SR; dosage modification may be necessary. Severe kidney disease contraindicates the use of Hdglim M 1mg/500mg Tablet SR. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Individuals with liver impairment should use Hdglim M 1mg/500mg Tablet SR cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Hdglim M 1mg/500mg Tablet SR should typically begin at a low dose; it's contraindicated in patients with severe liver dysfunction.
What if you forget to take Hdglim M 1mg/500mg Tablet SR :
Should you forget a dose of Hdglim M 1mg/500mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Hdglim M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
